Mersana Therapeutics (FRA:0M4) Days Sales Outstanding : 0.00 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Mersana Therapeutics Days Sales Outstanding?

Mersana Therapeutics's average Accounts Receivable for the three months ended in Dec. 2023 was €0.00 Mil. Mersana Therapeutics's Revenue for the three months ended in Dec. 2023 was €9.81 Mil. Hence, Mersana Therapeutics's Days Sales Outstanding for the three months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Mersana Therapeutics's Days Sales Outstanding or its related term are showing as below:

FRA:0M4' s Days Sales Outstanding Range Over the Past 10 Years
Min: 3.98 Med: 21.41 Max: 411.95
Current: 297.11

During the past 9 years, Mersana Therapeutics's highest Days Sales Outstanding was 411.95. The lowest was 3.98. And the median was 21.41.

FRA:0M4's Days Sales Outstanding is ranked worse than
87.53% of 890 companies
in the Biotechnology industry
Industry Median: 71.92 vs FRA:0M4: 297.11

Mersana Therapeutics's Days Sales Outstanding declined from Dec. 2022 (186.38) to Dec. 2023 (0.00).

Mersana Therapeutics Days Sales Outstanding Historical Data

The historical data trend for Mersana Therapeutics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mersana Therapeutics Days Sales Outstanding Chart

Mersana Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

3.88

411.96

305.86

Mersana Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															186.38	354.63	-	-	-

Competitive Comparison of Mersana Therapeutics's Days Sales Outstanding

For the Biotechnology subindustry, Mersana Therapeutics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mersana Therapeutics's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mersana Therapeutics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Mersana Therapeutics's Days Sales Outstanding falls into.

Mersana Therapeutics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Mersana Therapeutics's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (28.32	+	0)	/	1 )	/	33.796	*	365
=	28.32					/	33.796	*	365
=	305.86

Mersana Therapeutics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	9.813	*	365 / 4
=	0					/	9.813	*	365 / 4
=	0.00

Mersana Therapeutics (FRA:0M4) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Mersana Therapeutics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Mersana Therapeutics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Mersana Therapeutics (FRA:0M4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mersana Therapeutics Inc (FRA:0M4) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

MRSN:USA

Address

840 Memorial Drive, Cambridge, MA, USA, 02139

Website

https://www.mersana.com

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs include XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.

Mersana Therapeutics (FRA:0M4) Headlines

No Headlines